RALGPS1
Ras-specific guanine nucleotide-releasing factor RalGPS1
Also known as: KIAA0351, RALGEF2, RALGPS1A, RGPS1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JS13
- Gene
- RALGPS1
- Ensembl
- ENSG00000136828
- Chromosome
- 9
- Canonical length
- 557 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables guanyl-nucleotide exchange factor activity. Involved in regulation of Ral protein signal transduction. Predicted to be located in cytoplasm. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
557 residues, UniProt reviewed canonical sequence.
>Q5JS13|RALGPS1
1 MYKRNGLMAS VLVTSATPQG SSSSDSLEGQ SCDYASKSYD AVVFDVLKVT PEEFASQITL
61 MDIPVFKAIQ PEELASCGWS KKEKHSLAPN VVAFTRRFNQ VSFWVVREIL TAQTLKIRAE
121 ILSHFVKIAK KLLELNNLHS LMSVVSALQS APIFRLTKTW ALLNRKDKTT FEKLDYLMSK
181 EDNYKRTREY IRSLKMVPSI PYLGIYLLDL IYIDSAYPAS GSIMENEQRS NQMNNILRII
241 ADLQVSCSYD HLTTLPHVQK YLKSVRYIEE LQKFVEDDNY KLSLRIEPGS SSPRLVSSKE
301 DLAGPSAGSG SARFSRRPTC PDTSVAGSLP TPPVPRHRKS HSLGNNMMCQ LSVVESKSAT
361 FPSEKARHLL DDSVLESRSP RRGLALTSSS AVTNGLSLGS SESSEFSEEM SSGLESPTGP
421 CICSLGNSAA VPTMEGPLRR KTLLKEGRKP ALSSWTRYWV ILSGSTLLYY GAKSLRGTDR
481 KHYKSTPGKK VSIVGWMVQL PDDPEHPDIF QLNNPDKGNV YKFQTGSRFH AILWHKHLDD
541 ACKSNRPQVP ANLMSFELocalizationUniProt · AlphaFold · HPA
Whether an antibody against RALGPS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 37 nTPM
- duodenum: 29 nTPM
- retina: 29 nTPM
- small intestine: 27 nTPM
- spinal cord: 22 nTPM
- pituitary gland: 18 nTPM
Single-cell type
- thyrotrophs: 347 nCPM
- rod photoreceptor cells: 322 nCPM
- gonadotrophs: 320 nCPM
- epicardial cells: 305 nCPM
- renal collecting duct intercalated cells: 298 nCPM
- retinal ganglion cells: 290 nCPM
Immune cell
- memory B-cell: 2.3 nTPM
- neutrophil: 0.9 nTPM
- NK-cell: 0.8 nTPM
- eosinophil: 0.7 nTPM
- naive B-cell: 0.7 nTPM
- plasmacytoid DC: 0.7 nTPM
Brain region
- white matter: 63 nTPM
- pons: 62 nTPM
- medulla oblongata: 59 nTPM
- cerebellum: 58 nTPM
- thalamus: 54 nTPM
- cerebral cortex: 54 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.09
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular signal transduction
- Ras protein signal transduction
- regulation of Ral protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RALGPS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RALGPS1 as an antibody target. Whether an autoantibody or antibody against RALGPS1 could matter depends on whether native RALGPS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RALGPS1 is annotated at the cell surface, where native RALGPS1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RALGPS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...